A global leader in providing anti-infective treatments and other critical care therapies for serious and often life-threatening conditions
Xellia Pharmaceuticals is a specialty pharmaceutical company developing, manufacturing and commercializing anti-infective treatments against serious and often life-threatening bacterial and fungal infections.
Xellia is a world-leading trusted supplier of several important established antiinfective drugs, comprising active pharmaceutical ingredients as well as finished dosage forms, where the majority are injectable drug products.
Headquartered in Copenhagen, Denmark and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1800 employees globally.
From state-of-the-art manufacturing sites in the U.S., China, Denmark and Hungary to R&D sites in Norway and Croatia; Xellia Pharmaceuticals excels within innovative product development to deliver high quality products to its customers.
Our product portfolio of anti-bacterial and anti-fungal products used for the treatment of severe infections, including infections caused by multi-resistant bacteria and fungi, is the foundation for our growth strategy within the antibiotics’ sector.
Xellia is the leading supplier of important anti-infectives vancomycin and colistimethate sodium (CMS). Our success and strong market position is built on more than 120 years’ of pharmaceutical industry experience.
Xellia Pharmaceuticals focuses its R&D investments within injectable product technologies, as we are committed to researching solutions, which improve patients’ quality of life.
Supplying products to more than 80 countries worldwide and with more than 500 customers internationally, Xellia Pharmaceuticals places a high regard on maintaining strong relationships with its customers.
Our sales team serves as the first point of contact for customers, ensuring fast and accurate delivery of product information; through managing orders to delivery. Xellia Pharmaceuticals’ Global Business Operations Team serves as the main point of contact for customers to provide them with specialized support for all technical matters that may be associated with market entry and launch of products.
Working collaboratively with the sales team and cross-functionally with Xellia’s internal departments at all sites, Xellia Pharmaceuticals is dedicated to providing reliable outstanding service to its customers at all times.